EDUARDO TAMAYO GÓMEZ-rekin lankidetzan egindako argitalpenak (38)

2022

  1. PCR-based diagnosis of respiratory virus in postsurgical septic patients: A preliminary study before SARS-CoV-2 pandemic

    Medicine (United States), Vol. 101, Núm. 32, pp. E29902

2021

  1. Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  2. Parental Satisfaction with Autonomous Pediatric Ambulatory Surgery Units

    Quality Management in Health Care, Vol. 30, Núm. 3, pp. 145-152

2019

  1. Impact of empirical treatment with antifungal agents on survival of patients with candidemia

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 1, pp. 6-14

2018

  1. Evolution of the incidence, mortality, and cost of infective endocarditis in Spain between 1997 and 2014

    Journal of General Internal Medicine, Vol. 33, Núm. 10, pp. 1610-1613

  2. Impact of an ultraviolet air sterilizer on cardiac surgery patients, a randomized clinical trial

    Medicina Clinica, Vol. 151, Núm. 8, pp. 299-307

  3. Surgery for acute infective endocarditis: Epidemiological data from a Spanish nationwide hospital-based registry

    Interactive Cardiovascular and Thoracic Surgery, Vol. 27, Núm. 4, pp. 498-504

2017

  1. Antifungal treatment with echinocandins: A 10-year clinical experience

    Revista Espanola de Quimioterapia, Vol. 30, Núm. 6, pp. 413-421

  2. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity

    Annals of Intensive Care, Vol. 7, Núm. 1

2016

  1. Defining immunological dysfunction in sepsis: A requisite tool for precision medicine

    Journal of Infection, Vol. 72, Núm. 5, pp. 525-536

  2. Impact of ventilator-associated pneumonia on mortality and epidemiological features of patients with secondary peritonitis

    Annals of Intensive Care, Vol. 6, Núm. 1

  3. Postbooster antibodies from humans as source of diphtheria antitoxin

    Emerging Infectious Diseases, Vol. 22, Núm. 7, pp. 1265-1267

  4. Procalcitonin cannot be used as a biomarker of infection in heart surgery patients with acute kidney injury

    Journal of Critical Care, Vol. 33, pp. 233-239

2015

  1. Preventing sepsis

    The Lancet Infectious Diseases

  2. The original sins of clinical trials with intravenous immunoglobulins in sepsis

    Critical Care

  3. Transcriptomic correlates of organ failure extent in sepsis

    Journal of Infection, Vol. 70, Núm. 5, pp. 445-456

2014

  1. Quantification of IgM molecular response by droplet digital PCR as a potential tool for the early diagnosis of sepsis

    Critical Care

2012

  1. Evolution of neutrophil apoptosis in septic shock survivors and nonsurvivors

    Journal of Critical Care, Vol. 27, Núm. 4, pp. 415.e1-415.e11

  2. Ventilator-associated pneumonia is an important risk factor for mortality after major cardiac surgery

    Journal of Critical Care, Vol. 27, Núm. 1, pp. 18-25

2011

  1. Early natural killer cell counts in blood predict mortality in severe sepsis.

    Critical care (London, England), Vol. 15, Núm. 5